537
Views
31
CrossRef citations to date
0
Altmetric
Reviews

Pharmacotherapy of diabetic foot osteomyelitis

, , , &
Pages 3033-3047 | Published online: 02 Dec 2009

Bibliography

  • Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364:369-79
  • Cierny III G, Mader JT, Penninck JJ. A Clinical staging system for adult osteomyelitis. Contemp Orthop 1985;10:17-37
  • Waldvogel FA, Medoff G, Swartz MN. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 1970;282:198-206
  • Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996;13(Suppl 1):S6-11
  • Ragnarsson Tennvall G, Apelqvist J, Eneroth M. Costs of deep foot infections in patients with diabetes mellitus. Pharmacoeconomics 2000;18:225-38
  • Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003;361:1545-51
  • United States Department of Labor. Bureau of Labor Statistics, Consumer Price Index Inflation Calculator. Washington, DC: 2008. Available from: http://www.bls.gov/data/inflation_calculator.htm. [Last accessed 3 Nov 2009]
  • Lavery LA, Armstrong DG, Wunderlich RP, Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006;29:1288-93
  • Lipsky BA, Berendt AR, Deery HG, Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39:885-910
  • International Working Group on the Diabetic Foot (IWGDF). International consensus on the diabetic foot and supplements. In: Apelqvist J, Bakker K, Van Houtum WH, et al., editors [DVD]. Amsterdam, Netherlands: International Diabetes Federation; 2003
  • Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004;20(Suppl 1):90-5
  • Lavery LA, Armstrong DG, Murdoch DP, Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 2007;44:562-5
  • Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997;25:1318-26
  • Rajbhandari SM, Sutton M, Davies C, ‘Sausage toe’: a reliable sign of underlying osteomyelitis. Diabet Med 2000;17:74-7
  • Lavery LA, Walker SC, Harkless LB, Felder-Johnson K. Infected puncture wounds in diabetic and nondiabetic adults. Diabetes Care 1995;18:1588-91
  • Gardner SE, Frantz RA, Troia C, A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. Ostomy Wound Manage 2001;47:40-7
  • Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997;18:716-22
  • Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996;156:2373-6
  • Eneroth M, Apelqvist J, Stenstrom A. Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int 1997;18:716-22
  • Armstrong DG, Perales TA, Murff RT, Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc 1996;86:224-7
  • Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC. Puncture wounds: the frequency of normal laboratory values in the face of severe foot infections of the foot in diabetic and non-diabetic adults. Am J Med 1996;101:521-5
  • Newman LG, Waller J, Palestro CJ, Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991;266:1246-51
  • Grayson ML, Balaugh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3
  • Shone A, Burnside J, Chipchase S, Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes. Diabetes Care 2006;29:945
  • Lavery LA, Armstrong DG, Peters EJ, Lipsky BA. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Diabetes Care 2007;30:270-4
  • Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc 2001;91:445-50
  • Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg 1996;34:280-3
  • Sella EJ. Current concepts: diagnostic imaging of the diabetic foot. Foot Ankle Int 2009;30:5688-76
  • Donovan A, Schweitzer ME. Current concepts in imaging diabetic pedal osteomyelitis. Radiol Clin North Am 2008;46:1105-24,vii
  • Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med 2009;39:52-65
  • Berendt AR, Peters EJ, Bakker K, Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 2008;24(Suppl 1):S145-61
  • Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med 1996;101:550-61
  • Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis 2004;39(Suppl 2):S115-22
  • van Baal JG. Surgical treatment of the infected diabetic foot. Clin Infect Dis 2004;39(Suppl 2):S123-8
  • Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005;366:1704-10
  • Melamed E, Salman S, Peled E, Zinman C. Cement antibiotic spacer for the salvage of diabetic osteomyelitis. Presented at the American Orthopaedic Foot and Ankle Society 23rd Annual Summer Meeting [Poster 220], Toronto, Canada July 13-15, 2007
  • Klemm K. Gentamicin-PMMA-beads in treating bone and soft tissue infections. Zentralbl Chir 1979;104:934-42
  • Jerosch J, Lindner N, Fuchs S. Results of long-term therapy of chronic, post-traumatic osteomyelitis with gentamycin PMMA chains. Unfallchirurg 1995;98:338-43
  • Walenkamp GH, Kleijn LL, de LM. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1 – 12 years. Acta Orthop Scand 1998;69:518-22
  • Kelm J, Anagnostakos K, Regitz T, MRSA-infections-treatment with intraoperatively produced gentamycin-vancomycin PMMA beads. Chirurg 2004;75:988-95
  • Blaha JD, Calhoun JH, Nelson CL, Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop Relat Res 1993;295:8-12
  • Wright BA, Roberts CS, Seligson D, Cost of antibiotic beads is justified: a study of open fracture wounds and chronic osteomyelitis. J Long Term Eff Med Implants 2007;17:181-5
  • Chang W, Colangeli M, Colangeli S, Adult osteomyelitis: debridement versus debridement plus osteoset T pellets. Acta Orthop Belg 2007;73:238-43
  • Kent ME, Rapp RP, Smith KM. Antibiotic beads and osteomyelitis: here today, what's coming tomorrow? Orthopedics 2006;29:599-603
  • Galkowska H, Podbielska A, Olszewski WL, Epidemiology and prevalence of methicillin-resistant staphylococcus aureus and staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers. Diabetes Res Clin Pract 2009;84:187-93
  • Tentolouris N, Petrikkos G, Vallianou N, Prevalence of methicillin-resistant staphylococcus aureus in infected and uninfected diabetic foot ulcers. Clin Microbiol Infect 2006;12:186-9
  • Varaiya AY, Dogra JD, Kulkarni MH, Bhalekar PN. Extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae in diabetic foot infections. Indian J Pathol Microbiol 2008;51:370-2
  • Yates CJ, May K, Hale T, Wound chronicity, inpatient care and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Diabetes Care 2009;32(10):1907-9
  • Senneville E, Morant H, Descamps D, Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis 2009;48:888-93
  • Conterno LO, da Silva Filho CR. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2009;3:CD004439
  • Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005;9:127-38
  • Bamberger DM, Daus GP, Gerding DN. Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 1987;83:653-60
  • Norden CW. Lessons learned from animal models of osteomyelitis. Rev Infect Dis 1988;10:103-10
  • Venkatesan P, Lawn S, Macfarlane RM, Conservative management of osteomyelitis in the feet of diabetic patients. Diabet Med 1997;14:487-90
  • Pittet D, Wyssa B, Herter-Clavel C, Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Arch Intern Med 1999;159:851-6
  • Wilson KH, Kauffman CA. Oral antibiotic therapy for osteomyelitis of the foot in diabetic patients. South Med J 1985;78:223-4
  • Peterson LR, Lissack LM, Canter K, Therapy of lower extremity infections with ciprofloxacin in patients with diabetes mellitus, peripheral vascular disease, or both. Am J Med 1989;86:801-8
  • Embil JM. The management of diabetic foot osteomyelitis. Diabet Foot 2000;3:76-84
  • Landersdorfer CB, Bulitta JB, Kinzig M, Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet 2009;48:89-124
  • Norden C, Gillespie WJ, Nade S. Diagnosis and management. Infections and bones and joints. Boston, MA: Blackwell; 1994
  • Levison ME. Pharmacodynamics of antimicrobial drugs. Infect Dis Clin North Am 2004;18:451-65,vii
  • Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect 2001;7:589-96
  • Andes D, Craig WA. Pharmacokinetics and pharmacodynamics of outpatient intravenous antimicrobial therapy. Infect Dis Clin North Am 1998;12:849-60,vi
  • McKinnon PS, Davis SL. Pharmacokinetic and pharmacodynamic issues in the treatment of bacterial infectious diseases. Eur J Clin Microbiol Infect Dis 2004;23:271-88
  • Graziani AL, Lawson LA, Gibson GA, Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother 1988;32:1320-2
  • Raymakers JT, Schaper NC, van der Heyden JJ, Penetration of ceftazidime into bone from severely ischaemic limbs. J Antimicrob Chemother 1998;42:543-5
  • Raymakers JT, Houben AJ, van der Heyden JJ, The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb. Diabet Med 2001;18:229-34
  • Berger SA, Barza M, Haher J, Penetration of clindamycin into decubitus ulcers. Antimicrob Agents Chemother 1978;14:498-9
  • Schintler MV, Traunmuller F, Metzler J, High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother 2009;64(3):574-8
  • Fitzgerald RH Jr. Antibiotic distribution in normal and osteomyelitic bone. Orthop Clin North Am 1984;15:537-46
  • Vuagnat A, Stern R, Lotthe A, High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion. J Clin Pharm Ther 2004;29:351-7
  • Munckhof WJ, Carney J, Neilson G, Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics. Int J Antimicrob Agents 2005;25:514-22
  • Freeman CD, Nicolau DP, Belliveau PP, Nightingale CH. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice. J Antimicrob Chemother 1997;39:677-86
  • Salvati EA, Callaghan JJ, Brause BD, Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res 1986;207:83-93
  • Walenkamp GH, Vree TB, van Rens TJ. Gentamicin-PMMA beads. Pharmacokinetic and nephrotoxicological study. Clin Orthop Relat Res 1986;205:171-83
  • van Raaij TM, Visser LE, Vulto AG, Verhaar JA. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty. J Arthroplasty 2002;17:948-50
  • Haydon RC, Blaha JD, Mancinelli C, Koike K. Audiometric thresholds in osteomyelitis patients treated with gentamicin-impregnated methylmethacrylate beads (septopal). Clin Orthop Relat Res 1993;295:43-6
  • Graham AC, Mercier RC, Achusim LE, Pai MP. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis. Ann Pharmacother 2004;38:936-41
  • Rybak MJ, Lomaestro BM, Rotscahfer JC, Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325-7
  • Matthews PC, Conlon CP, Berendt AR, Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007;60:356-62
  • Karamanis EM, Matthaiou DK, Moraitis LI, Falagas ME. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) 2008; 33:E297-304
  • de Lalla F, Pellizzer G, Strazzabosco M, Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001;45:1094-8
  • A multicenter, randomized, double-blind, comparison study of the safety and efficacy of a once-daily dose of tigecycline versus ertapenem for the treatment of foot infections in subjects with diabetes. ClinicalTrials.gov identifier: NCT00366249. Available from: http://clinicaltrials.gov/ct2/show/record/NCT00366249 [Last accessed 15 May 2009]
  • A prospective, multicenter, double-blind with in-house blinding, randomized, comparative study to evaluate the efficacy, safety, and tolerability, of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in adults. ClinicalTrials.gov identifier: NCT00229112. Available from: http://clinicaltrials.gov/ct2/show/NCT00229112 [Last accessed 27 April 2009]
  • Jeffcoate WJ, Game F, Lipsky BA, Berendt AR. Diabetes osteomyelitis management and outcome (DOMO) study. Available at: http://www.domo.org.uk/ [Last accessed 5 January 2008]
  • Hartemann-Heurtier A. comparison of medical and medical-surgical management of diabetic foot osteomyelitis. ClinicalTrials.gov identifier: NCT00578890. Available from: http://clinicaltrials.gov/ct2/show/record/NCT00578890 [Last accessed 11 February 2009]
  • Rice DA, Mendez-Vigo L. Daptomycin in bone and joint infections: a review of the literature. Arch Orthop Trauma Surg 2009;129(11):1495-504
  • Senneville E, Lombart A, Beltrand E, Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 2008;31:637-42
  • Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004;351:1645-54
  • Lipsky BA, Itani K, Norden C. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. Clin Infect Dis 2004;38:17-24
  • Tascini C, Gemignani G, Palumbo F, Clinical and microbiological efficacy of colistin therapy alone or in combination as treatment for multidrug resistant Pseudomonas aeruginosa diabetic foot infections with or without osteomyelitis. J Chemother 2006;18:648-51
  • Embil JM, Rose G, Trepman E, Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 2006;27:771-9
  • Stengel D, Gorzer E, Schintler M, Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin. J Chemother 2005;17:527-35
  • Yadlapalli N, Vaishnar A, Sheehan P. Conservative management of diabetic foot ulcers complicated by osteomyelitis. Wounds 2002;14:31-5
  • de LF, Pellizzer G, Strazzabosco M, Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chemother 2001;45:1094-8
  • Senneville E, Yazdanpanah Y, Cazaubiel M, Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001;48:927-30
  • Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 2000;39:124-30

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.